Our practice participates in many national and international clinical trials with the purpose of discovering improved therapies for retinal diseases. Each clinical trial is approved by an institutional review board (IRB) prior to initiation. Our physicians also evaluate each clinical trial for safety prior to entering into the trial.
RAWNY participates in a number of clinical trials evaluating the use of pharmaceutical drugs in treating a variety of retinal diseases, such as:
- Wet Macular Degeneration
- Dry Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
Retina Associates of Western NY became interested in clinical trials as a way to advance medicine and to ensure patients had access to cutting edge care. In the last decade, the department has grown exponentially, and as of today we are nearing our 80th trial participation. With studies ranging from 6 months to three years in length, we have maintained an excellent retention rate. This is in part to our Study Coordinators, Meg, Mary Jo and Jessica. Each clinical trial participant is cared for by our dedicated research study team, which includes the study coordinators, photographers, technicians and physicians. Unique to Retina Associates of Western NY is that every visit from beginning to end is done within our suite.
We are proud of our legacy. A legacy that allowed us to be a study site that helped bring the current state of the art retinal medications to the market. Our research effectively changed how physicians treat patients with Age-Related Macular Degeneration worldwide, and now offers hope where once there wasn’t any. Today, we stand upon the precipice of another potential life altering change. We are participating in an observational trial that has the potential to lead to individualized therapies that further alter the landscape of ophthalmology.
What is a Clinical Trial?
If you are interested in participating in a clinical trial, fill out this form and a clinical trial coordinator will contact you.